The PCAST Report on Pharmaceutical Innovation: Implications for the FDA

    loading  Checking for direct PDF access through Ovid

Abstract

In September 2012, the President's Council of Advisors on Science and Technology (PCAST) released the report “Propelling Innovation in Drug Discovery, Development and Evaluation.” A product of discussions with many stakeholders, the report reiterates current problems in drug development, including diminished return on basic biomedical research. The report calls for doubling the current annual output of innovative new medicines— an ambitious goal. Recommendations and resulting initiatives will probably affect the FDA's drug regulatory programs.

Related Topics

    loading  Loading Related Articles